BIOMARKERS: CAN THEY REALLY GUIDE OUR DAILY PRACTICE?-Reference-Cited by-同舟云学术

BIOMARKERS: CAN THEY REALLY GUIDE OUR DAILY PRACTICE?

Published:2022-07-24 Issue:3S Volume:59 Page:16-20
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:Shock

Author:

Tsangaris Iraklis¹,Antonakos Nikolaos²,Fantoni Massimo,Kaplanski Gilles³,Kyriazopoulou Evdoxia¹,Veas Francisco,Clemens Mark⁴

Affiliation:

1. 2nd Department of Critical Care Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece

2. 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece

3. Division of Internal Medicine and Clinical Immunology, Hôpital de la Conception, C2VN-INSERM U1263, Aix-Marseille University, Marseille, France

4. Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina

Abstract

ABSTRACT Optimal management of septic patients requires accurate assessment of both current severity status and prognosis. Since the 1990s, substantial advances have been made in the use of circulating biomarkers for such assessments. This summary of the session on “Biomarkers: can they really use guide our daily practice?” presented at the 2021 WEB-CONFERENCE OF THE EUROPEAN SHOCK SOCIETY, 6 November 2021. These biomarkers include ultrasensitive detection of bacteremia, circulating soluble urokina-type plasminogen activator receptor (suPAR), C-reactive protein (CRP) and ferritin and procalcitonin. In addition, the potential application of novel multiwavelength optical biosensor technology allows noninvasive monitoring of multiple metabolites that can be used to assess severity and prognosis in septic patients. The application these biomarkers and improved technologies provide the potential for improved personalized management of septic patients.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference40 articles.

1. The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients;Cancer Res,1998

2. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau;Int J Tuberc Lung Dis,2002

3. Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases;J Neuroimmunol,2002

4. Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients;J Acquir Immune Defic Syndr,2004

5. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis;Inflammation,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BIOINFORMATICS APPLICATIONS UNDER CONDITION CONTROL: HIGH DIAGNOSTIC VALUE OF DDX47 IN REAL MEDICAL SETTINGS;Shock;2024-01

2. SECRETED TRYPTOPHANYL-tRNA SYNTHETASE 1 IS A PROGNOSTIC MARKER IN SEPSIS PATIENTS WITHOUT MONOCYTOPENIA;Shock;2023-10-20

3. Биологические маркеры сепсиса;Microbiology Independent Research Journal (MIR Journal);2023

4. Biological markers of sepsis;Microbiology Independent Research Journal (MIR Journal);2023